SBU Agreements
Abiomed, Inc. ~ Effective 1/30/2008 until further amended.
Alexion Pharmaceuticals, Inc. - Effective 2/18/2020 - 2/17/2025
Alpha Oncology Inc. - Effective 10/18/11
Beckman Coulter ~ Effective 2/16/2011 - 2/15/2016
Cardiac Pacemakers, Inc. - Effective 11/20/2006
Children's Oncology Group Foundation, Inc. - Effective 10/3/2022
Correlogic Systems, Inc - Effective 5/8/2006
Criterium, Inc. (CRO for Academic Breast Cancer Consortium ("ABRCC")) - Effective 9/23/2021 - 9/22/2026
Genzyme Corp. - Effective 4/25/2011
Ilex Pharmaceuticals Corp.
Incyte Corporation - Effective 4/5/2017 - 4/4/2027
Karyopharm Therapeutics - Effective 11/10/2017 - 11/9/2024
National Marrow Donor Program - Effective 11/27/2018
NRG Oncology Foundation, Inc. - Effective 3/1/2019 - 2/28/2025
Pharmacyclics, LLC. - Effective 4/10/2017 - 4/9/2022
Public Health Institute - Non-Industry Funding Effective 3/1/2024; Industry Funding Effective 5/15/2021
*For RF Master Clinical Trial Agreements and Master Confidentiality Agreements, please visit RF SUNY's website linked below.